Applied Therapeutics, Inc.APLT
| Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Cash and cash equivalents | 19 | 57 | 54 | 17 | 50 |
---|
Investments | 20 | 39 | 27 | 14 | - |
---|
Prepaid expenses and other current assets | 7 | 6 | 8 | 7 | 4 |
---|
Security Deposit And Leasehold Improvements, Current | - | - | - | - | 0 |
---|
Total current assets | 46 | 103 | 88 | 37 | 54 |
---|
Prepaid expenses and other current assets | 7 | 6 | 8 | 7 | 4 |
---|
Total current assets | 46 | 103 | 88 | 37 | 54 |
---|
Operating lease right-of-use asset | 2 | 2 | 1 | 1 | 0 |
---|
Security deposits and leasehold improvements | 0 | 0 | 0 | 0 | - |
---|
Operating lease right-of-use asset | 2 | 2 | 1 | 1 | 0 |
---|
TOTAL ASSETS | 48 | 105 | 90 | 38 | 55 |
---|
Operating Lease, Liability, Current | 0 | 0 | 0 | 0 | 0 |
---|
Accounts payable | 9 | 1 | 9 | 5 | 2 |
---|
Accrued expenses and other current liabilities | 5 | 20 | 17 | 15 | 15 |
---|
Warrant liabilities | - | - | - | 14 | 54 |
---|
Total current liabilities | 14 | 21 | 26 | 33 | 71 |
---|
Operating Lease, Liability, Noncurrent | 2 | 1 | 1 | 0 | 0 |
---|
Clinical Holdback, Noncurrent | - | - | - | 0 | 1 |
---|
Total noncurrent liabilities | 2 | 1 | 1 | 1 | 1 |
---|
Total liabilities | 16 | 23 | 27 | 34 | 72 |
---|
Common Stock, Value, Issued | 0 | 0 | 0 | 0 | 0 |
---|
Additional paid-in capital | 99 | 243 | 329 | 353 | 451 |
---|
Accumulated other comprehensive income | -0 | -0 | -0 | 0 | - |
---|
Accumulated deficit | -67 | -161 | -266 | -349 | -469 |
---|
Total stockholders' (deficit)/equity | 33 | 82 | 63 | 4 | -17 |
---|
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT)/EQUITY | 48 | 105 | 90 | 38 | 55 |
---|